Effect of therapeutic drug monitoring on outcome in antiretroviral experienced HIV-infected individuals

This publication has 10 references indexed in Scilit:

• Determination of serum levels of thirteen human immunodeficiency virus-suppressing drugs by high-performance liquid chromatography
  Journal of Chromatography A, 2001
• Reliability of Cmin: inhibitory concentration ratios.
  The Journal of Infectious Diseases, 2001
• Efavirenz plasma levels can predict treatment failure and central nervous system side effects in HIV-1-infected patients
  AIDS, 2001
• Paronychia in Association with Indinavir Treatment
  Clinical Infectious Diseases, 2001
• Efavirenz-Induced Decrease in Plasma Amprenavir Levels in Human Immunodeficiency Virus-Infected Patients and Correction by Ritonavir
  Antimicrobial Agents and Chemotherapy, 2000
• Drug Resistance and Predicted Virologic Responses to Human Immunodeficiency Virus Type 1 Protease Inhibitor Therapy
  The Journal of Infectious Diseases, 2000
• Adherence to Protease Inhibitor Therapy and Outcomes in Patients with HIV Infection
  Annals of Internal Medicine, 2000
• Drug Susceptibility in HIV Infection After Viral Rebound in Patients Receiving Indinavir-Containing Regimens
  JAMA, 2000
• Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus Infection
  New England Journal of Medicine, 1998
• Saquinavir pharmacokinetics alone and in combination with ritonavir in HIV-infected patients
  AIDS, 1997